Works matching DE "GOLIMUMAB"

Results: 323

Early MOnitoring of REsponse (MORE) to Golimumab Therapy: Results of a Multicentre, Prospective Observational Trial.

Published in:

Digestive Diseases, 2023, v. 41, n. 2, p. 239, doi. 10.1159/000527460

By:

Helwig, Ulf;
Krause, Thomas Helmut;
Maaser, Christian;
Büning, Jürgen;
Drabik, Attyla;
Blömacher, Margit;
Plachta-Danielzik, Sandra;
Teich, Niels;
Krummenerl, Annette;
Sturm, Andreas;
Schwab, Matthias;
Schreiber, Stefan

Publication type:

Article

Current and Emerging Targeted Therapies for Ulcerative Colitis.

Published in:

Visceral Medicine, 2023, v. 39, n. 2, p. 46, doi. 10.1159/000530983

By:

Pietschner, Robert;
Rath, Timo;
Neurath, Markus F.;
Atreya, Raja

Publication type:

Article

Effectiveness and Factors Associated with Response to Golimumab in Japanese Patients with Ulcerative Colitis in Real Clinical Practice: The Phoenix Study.

Published in:

Inflammatory Intestinal Diseases, 2023, v. 8, n. 3, p. 115, doi. 10.1159/000533871

By:

Hirayama, Daisuke;
Motoya, Satoshi;
Ashida, Toshifumi;
Ando, Katsuyoshi;
Fujiya, Mikihiro;
Ito, Takahiro;
Furukawa, Shigeru;
Maemoto, Atsuo;
Katsurada, Takehiko;
Hinotsu, Shiro;
Sato, Noriko;
Mizuno, Naomi;
Ikawa, Yoshiko;
Nakase, Hiroshi

Publication type:

Article

Early-Phase Partial Mayo Score following Golimumab Treatment Is Associated with Endoscopic Improvement at 1 Year in Ulcerative Colitis: A post hoc Analysis of PURSUIT-J Randomized Controlled Trial.

Published in:

Inflammatory Intestinal Diseases, 2022, v. 7, n. 3/4, p. 155, doi. 10.1159/000526264

By:

Nagano, Katsumasa;
Imai, Yuya;
Ukyo, Yoshifumi;
Kobayashi, Taku;
Yokoyama, Seiji

Publication type:

Article

Effectiveness and Safety of Golimumab in the Treatment of Ulcerative Colitis: 52-Week Results from Post-Marketing Surveillance in Japan.

Published in:

Inflammatory Intestinal Diseases, 2022, v. 7, n. 3/4, p. 128, doi. 10.1159/000528185

By:

Nakamura, Shiro;
Asano, Teita;
Tanaka, Yoshihito;
Sugimoto, Kanami;
Yoshigoe, Shinichi;
Suzuki, Yasuo

Publication type:

Article

Golimumab for Rheumatoid Arthritis.

Published in:

Journal of Clinical Medicine, 2019, p. 387, doi. 10.3390/jcm8030387

By:

Pelechas, Eleftherios;
Voulgari, Paraskevi V.;
Drosos, Alexandros A.

Publication type:

Article

Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies.

Published in:

European Journal of Rheumatology, 2021, v. 8, n. 3, p. 120, doi. 10.5152/eurjrheum.2021.19207

By:

Genovese, Mark C.;
Durez, Patrick;
Fleischmann, Roy;
Yoshiya Tanaka;
Furst, Daniel;
Hisashi Yamanaka;
Korneva, Elena;
Vasyutin, Igor;
Tsutomu Takeuchi

Publication type:

Article

First case of demyelinating polyneuropathy probably related to treatment with golimumab.

Published in:

European Journal of Rheumatology, 2018, v. 5, n. 3, p. 201, doi. 10.5152/eurjrheum.2018.17193

By:

Díez, Francisco Javier Domínguez

Publication type:

Article

Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis.

Published in:

Rheumatology & Therapy, 2023, v. 10, n. 5, p. 1385, doi. 10.1007/s40744-023-00586-6

By:

Walsh, Jessica A.;
Saffore, Christopher D.;
Collins, Eric B.;
Ostor, Andrew

Publication type:

Article

Effect of Intravenous Golimumab on Fatigue and the Relationship with Clinical Response in Adults with Active Ankylosing Spondylitis in the Phase 3 GO-ALIVE Study.

Published in:

Rheumatology & Therapy, 2023, v. 10, n. 4, p. 983, doi. 10.1007/s40744-023-00556-y

By:

Deodhar, Atul;
Shiff, Natalie J.;
Gong, Cinty;
Chan, Eric K. H.;
Hsia, Elizabeth C.;
Lo, Kim Hung;
Akawung, Alianu;
Kim, Lilianne;
Xu, Stephen;
Reveille, John D.

Publication type:

Article

Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study.

Published in:

Rheumatology & Therapy, 2023, v. 10, n. 3, p. 659, doi. 10.1007/s40744-023-00533-5

By:

Bingham III, Clifton O.;
Black, Shawn;
Shiff, Natalie J.;
Xu, Stephen;
Langholff, Wayne;
Curtis, Jeffrey R.

Publication type:

Article

A Real-World Claims Database Study Assessing Long-Term Persistence with Golimumab Treatment in Patients with Rheumatoid Arthritis in Japan.

Published in:

Rheumatology & Therapy, 2023, v. 10, n. 3, p. 615, doi. 10.1007/s40744-023-00539-z

By:

Miyashiro, Masahiko;
Ishii, Yutaka;
Miyazaki, Celine;
Shimizu, Hirohito;
Masuda, Junya

Publication type:

Article

Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea.

Published in:

Rheumatology & Therapy, 2021, v. 8, n. 3, p. 1393, doi. 10.1007/s40744-021-00352-6

By:

Kim, Hyeongyeong;
Kim, Youngdoe;
Lee, YoungJa

Publication type:

Article

Incidence of Infusion Reactions and Clinical Effectiveness of Intravenous Golimumab Versus Infliximab in Patients with Rheumatoid Arthritis: The Real-World AWARE Study.

Published in:

Rheumatology & Therapy, 2021, v. 8, n. 4, p. 1551, doi. 10.1007/s40744-021-00354-4

By:

Curtis, Jeffrey R.;
Chakravarty, Soumya D.;
Black, Shawn;
Kafka, Shelly;
Xu, Stephen;
Langholff, Wayne;
Parenti, Dennis;
Greenspan, Andrew;
Schwartzman, Sergio

Publication type:

Article

Correction to: Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data.

Published in:

2020

By:

Shimizu, Hirohito;
Kobayashi, Hisanori;
Kanbori, Masayoshi;
Ishii, Yutaka

Publication type:

Correction Notice

Dose Adjustment of Methotrexate Administered Concomitantly with Golimumab for Rheumatoid Arthritis in Japanese Real-World Clinical Settings.

Published in:

Rheumatology & Therapy, 2020, v. 7, n. 4, p. 811, doi. 10.1007/s40744-020-00228-1

By:

Yamairi, Fumiko;
Yano, Toshiro;
Goto, Takashi;
Iwasaki, Tomohisa

Publication type:

Article

Association Between Nursing Support Levels and Effectiveness of Golimumab in the Management of Patients with Rheumatologic Diseases.

Published in:

Rheumatology & Therapy, 2020, v. 7, n. 2, p. 401, doi. 10.1007/s40744-020-00210-x

By:

Leroi, Hermine;
Badot, Valérie;
De Keyser, Filip;
Devinck, Mieke;
Geusens, Piet;
Kleimberg, Sandra;
Swinnen, Carine;
Roggeman, Chantal

Publication type:

Article

Golimumab as the First-, Second-, or at Least Third-Line Biologic Agent in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis: Post Hoc Analysis of a Noninterventional Study in Germany.

Published in:

Rheumatology & Therapy, 2020, v. 7, n. 2, p. 371, doi. 10.1007/s40744-020-00204-9

By:

Krüger, Klaus;
Burmester, Gerd Rüdiger;
Wassenberg, Siegfried;
Thomas, Matthias H.

Publication type:

Article

Looking Back on 2019 in Rheumatology and What to Expect from 2020.

Published in:

2020

By:

Fleischmann, Roy

Publication type:

Editorial

Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data.

Published in:

Rheumatology & Therapy, 2020, v. 7, n. 2, p. 311, doi. 10.1007/s40744-020-00198-4

By:

Shimizu, Hirohito;
Kobayashi, Hisanori;
Kanbori, Masayoshi;
Ishii, Yutaka

Publication type:

Article

A Review on the Effect of Tumor Necrosis Factor Inhibitors on Structural Progression in Early Axial Spondyloarthritis Using Magnetic Resonance Imaging.

Published in:

Rheumatology & Therapy, 2019, v. 6, n. 2, p. 139, doi. 10.1007/s40744-019-0141-y

By:

Li, Ko-Jen;
Jois, Ramesh;
Lichauco, Juan Javier;
Santos Estrella, Paul;
Llamado, Lyndon John;
Thorat, Amit Vilas;
Mahgoub, Ehab

Publication type:

Article

Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in Scotland.

Published in:

Rheumatology & Therapy, 2018, v. 5, n. 1, p. 57, doi. 10.1007/s40744-018-0108-4

By:

Borse, Rebekah H.;
Kachroo, Sumesh;
Brown, Chloe;
McCann, Eilish;
Insinga, Ralph P.

Publication type:

Article

Safety, Effectiveness, and Treatment Persistence of Golimumab in Elderly Patients with Rheumatoid Arthritis in Real-World Clinical Practice in Japan.

Published in:

Rheumatology & Therapy, 2018, v. 5, n. 1, p. 135, doi. 10.1007/s40744-018-0101-y

By:

Okazaki, Masateru;
Kobayashi, Hisanori;
Shimizu, Hirohito;
Ishii, Yutaka;
Yajima, Tsutomu;
Kanbori, Masayoshi

Publication type:

Article

Real-World Treatment Patterns for Golimumab and Concomitant Medications in Japanese Rheumatoid Arthritis Patients.

Published in:

Rheumatology & Therapy, 2018, v. 5, n. 1, p. 185, doi. 10.1007/s40744-018-0095-5

By:

Okazaki, Masateru;
Kobayashi, Hisanori;
Ishii, Yutaka;
Kanbori, Masayoshi;
Yajima, Tsutomu

Publication type:

Article

Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective.

Published in:

Rheumatology & Therapy, 2017, v. 4, n. 2, p. 427, doi. 10.1007/s40744-017-0083-1

By:

Borse, Rebekah;
Brown, Chloe;
Muszbek, Noemi;
Chaudhary, Mohammad;
Kachroo, Sumesh

Publication type:

Article

Golimumab for Polyarticular Juvenile Idiopathic Arthritis and Psoriatic Arthritis: Pharmacologic and Clinical Considerations.

Published in:

Life (2075-1729), 2023, v. 13, n. 7, p. 1601, doi. 10.3390/life13071601

By:

McIntosh, Sydney Moore;
Kerut, Christian;
Hollenshead, Payton P.;
Askins, Dorothy H.;
Mansourian, Kasra;
Palowsky, Zachary R.;
Allampalli, Varsha;
Ahmadzadeh, Shahab;
Shekoohi, Sahar;
Kaye, Alan D.

Publication type:

Article

Probable Drug Interaction Between Etanercept and Cyclosporine Resulting in Clinically Unexpected Low Trough Concentrations: First Case Report.

Published in:

Frontiers in Pharmacology, 2020, v. 11, p. 1, doi. 10.3389/fphar.2020.00939

By:

Wen, Haini;
Chen, Dongping;
Lu, Jiaqian;
Jiao, Zheng;
Chen, Bin;
Zhang, Bin;
Ye, Chaoyang;
Liu, Li

Publication type:

Article

Emerging Topical and Systemic JAK Inhibitors in Dermatology.

Published in:

Frontiers in Immunology, 2019, v. 10, p. 1, doi. 10.3389/fimmu.2019.02847

By:

Solimani, Farzan;
Meier, Katharina;
Ghoreschi, Kamran

Publication type:

Article

Restored and Enhanced Memory T Cell Immunity in Rheumatoid Arthritis After TNFα Blocker Treatment.

Published in:

Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00887

By:

Khanniche, Asma;
Zhou, Ling;
Jiang, Bin;
Song, Jing;
Jin, Yanhua;
Yin, Jian;
Wang, Shujun;
Ji, Ping;
Shen, Hao;
Wang, Ying;
Xu, Huji

Publication type:

Article

Efficacy and safety of golimumab 52-week maintenance therapy in Japanese patients with moderate to severely active ulcerative colitis: a phase 3, double-blind, randomized, placebo-controlled study-(PURSUIT-J study).

Published in:

2017

By:

Hibi, Toshifumi;
Imai, Yuya;
Senoo, Asako;
Ohta, Kentaro;
Ukyo, Yoshifumi

Publication type:

journal article

The Efficacy of Golimumab Against Non-Infectious Uveitis: A PRISMA-Compliant Systematic Review and Meta-Analysis.

Published in:

Ocular Immunology & Inflammation, 2023, v. 31, n. 5, p. 1013, doi. 10.1080/09273948.2022.2081584

By:

Okada, Katsuya;
Zhou, Yi;
Hashida, Noriyasu;
Takagi, Tatsuya;
Tian, Yu-Shi

Publication type:

Article

Use of Anti-Tumour Necrosis Factor-Alpha Agents in the Management of HLA-B-27-Associated Uveitis: The First Case Series from India.

Published in:

2021

By:

Lakra, Ruchika;
Shah, Amravi;
Kaushik, Viswanath;
Biswas, Jyotirmay;
Dutta Majumder, Parthopratim

Publication type:

journal article

Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet's Disease.

Published in:

2019

By:

Fabiani, Claudia;
Sota, Jurgen;
Vitale, Antonio;
Frediani, Bruno;
Galeazzi, Mauro;
Cantarini, Luca;
Rigante, Donato;
Emmi, Giacomo;
Vannozzi, Lorenzo;
Bacherini, Daniela;
Franceschini, Rossella;
Tosi, Gian Marco

Publication type:

journal article

Long-term Treatment with Golimumab for Severe Uveitis.

Published in:

Ocular Immunology & Inflammation, 2014, v. 22, n. 2, p. 90, doi. 10.3109/09273948.2013.844265

By:

Miserocchi, Elisabetta;
Modorati, Giulio;
Pontikaki, Irene;
Meroni, Pier Luigi;
Gerloni, Valeria

Publication type:

Article

Behçet Disease-associated Uveitis Successfully Treated with Golimumab.

Published in:

Ocular Immunology & Inflammation, 2013, v. 21, n. 2, p. 160, doi. 10.3109/09273948.2012.741744

By:

Mesquida MD, Marina;
Victoria Hernández, María;
Llorenç MD, Victor;
Pelegrín, Laura;
Espinosa, Gerard;
Dick, Andrew D.;
Adán, Alfredo

Publication type:

Article

The Association of TNF-Alpha Inhibitors and Development of IgA Nephropathy in Patients with Rheumatoid Arthritis and Diabetes.

Published in:

Case Reports in Nephrology, 2020, p. 1, doi. 10.1155/2020/9480860

By:

Premužić, Vedran;
Padjen, Ivan;
Cerovec, Mislav;
Ćorić, Marijana;
Jelaković, Bojan;
Anić, Branimir

Publication type:

Article

The Importance of Considering Differences in Study Design in Network Meta-analysis: An Application Using Anti-Tumor Necrosis Factor Drugs for Ulcerative Colitis.

Published in:

Medical Decision Making, 2017, v. 37, n. 8, p. 894, doi. 10.1177/0272989X17711933

By:

Cameron, Chris;
Ewara, Emmanuel;
Wilson, Florence R.;
Varu, Abhishek;
Dyrda, Peter;
Hutton, Brian;
Ingham, Michael

Publication type:

Article

Psoriasiform exfoliative erythroderma induced by golimumab.

Published in:

Clinical & Experimental Dermatology, 2014, v. 39, n. 7, p. 813, doi. 10.1111/ced.12402

By:

Mateo, S.;
García‐Martínez, F. J.;
Sánchez‐Aguilar, D.;
Amarelo, J.;
Toribio, J.

Publication type:

Article

Benefit--risk assessment of golimumab in the treatment of refractory ulcerative colitis.

Published in:

Drug, Healthcare & Patient Safety, 2016, v. 8, p. 1, doi. 10.2147/DHPS.S62649

By:

Pugliese, Daniela;
Felice, Carla;
Landi, Rosario;
Papa, Alfredo;
Guidi, Luisa;
Armuzzi, Alessandro

Publication type:

Article

Treatment persistence of subcutaneous TNF inhibitors among Australian patients with immune-mediated rheumatic disease (IMRD).

Published in:

Open Access Rheumatology: Research & Reviews, 2018, v. 11, p. 151, doi. 10.2147/OARRR.S179704

By:

Acar, Mustafa;
Juneja, Prabhjot;
Handel, Malcolm

Publication type:

Article

Quantitative comparison of the neutralizing capacity, immunogenicity and cross-reactivity of anti-TNF-α biologicals and an Infliximab-biosimilar.

Published in:

PLoS ONE, 2018, v. 13, n. 12, p. 1, doi. 10.1371/journal.pone.0208922

By:

Buurman, D. J.;
Blokzijl, T.;
Festen, E. A. M.;
Pham, B. T.;
Faber, K. N.;
Brouwer, E.;
Dijkstra, G.

Publication type:

Article

Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in Switzerland.

Published in:

Therapeutic Advances in Gastroenterology, 2022, v. 15, p. 1, doi. 10.1177/17562848221074188

By:

Perrig, Kathrin;
Krupka, Niklas;
Jordi, Sebastian Bruno Ulrich;
Rossel, Jean-Benoît;
Biedermann, Luc;
Greuter, Thomas;
Schreiner, Philipp;
Vavricka, Stephan R.;
Juillerat, Pascal;
Burri, Emanuel;
Zimmermann, Dorothee;
Maillard, Michel H.;
Sulz, Michael Christian;
Brand, Stephan;
Rogler, Gerhard;
Misselwitz, Benjamin

Publication type:

Article

Infliximab, adalimumab, golimumab, vedolizumab and tofacitinib in moderate to severe ulcerative colitis: comparative cost-effectiveness study in Poland.

Published in:

Therapeutic Advances in Gastroenterology, 2020, v. 13, p. 1, doi. 10.1177/1756284820941179

By:

Petryszyn, Pawel;
Ekk-Cierniakowski, Pawel;
Zurakowski, Grzegorz

Publication type:

Article

Infliximab, adalimumab, golimumab, vedolizumab and tofacitinib in moderate to severe ulcerative colitis: comparative cost-effectiveness study in Poland.

Published in:

Therapeutic Advances in Gastroenterology, 2020, v. 13, p. 1, doi. 10.1177/1756284820941179

By:

Petryszyn, Pawel;
Ekk-Cierniakowski, Pawel;
Zurakowski, Grzegorz

Publication type:

Article

Golimumab in the treatment of ulcerative colitis.

Published in:

Therapeutic Advances in Gastroenterology, 2019, v. 12, p. N.PAG, doi. 10.1177/1756284818821266

By:

Cunningham, Georgina;
Samaan, Mark A.;
Irving, Peter M.

Publication type:

Article

Golimumab in the treatment of ulcerative colitis.

Published in:

Therapeutic Advances in Gastroenterology, 2019, v. 12, p. N.PAG, doi. 10.1177/1756284818821266

By:

Cunningham, Georgina;
Samaan, Mark A.;
Irving, Peter M.

Publication type:

Article

Population Pharmacokinetics and Exposure‐Response Modeling Analyses of Golimumab in Children and Young Adults With Recently Diagnosed Type 1 Diabetes.

Published in:

Journal of Clinical Pharmacology, 2023, v. 63, n. 6, p. 721, doi. 10.1002/jcph.2217

By:

Lee, Jong Bong;
Zhou, Wangda;
Xu, Zhenhua;
Hedrick, Joseph A.;
Leu, Jocelyn H.

Publication type:

Article

Population Pharmacokinetics and Exposure‐Response Modeling Analyses of Golimumab in Children With Moderately to Severely Active Ulcerative Colitis.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 4, p. 590, doi. 10.1002/jcph.1353

By:

Xu, Yan;
Adedokun, Omoniyi J.;
Chan, Daphne;
Hu, Chuanpu;
Xu, Zhenhua;
Strauss, Richard S.;
Hyams, Jeffrey S.;
Turner, Dan;
Zhou, Honghui

Publication type:

Article

Improvement of clinical and radiological manifestations of coxitis in patients with ankylosing spondylitis treated with tumor necrosis factor‐α inhibitor golimumab: Results of a 24‐Month prospective observation study (GO‐COX Study).

Published in:

International Journal of Rheumatic Diseases, 2023, v. 26, n. 7, p. 1321, doi. 10.1111/1756-185X.14742

By:

Erdes, Shandor;
Agafonova, Ekaterina M.;
Timokhina, Daria G.;
Davidian, Satenik Y.;
Zemerova, Elena V.;
Kulikov, Aleksey I.;
Markova, Olga G.;
Achikyan, Vladimir F.

Publication type:

Article

Quality of life and productivity loss in patients with ankylosing spondylitis using tumor necrosis factor inhibitors.

Published in:

International Journal of Rheumatic Diseases, 2023, v. 26, n. 7, p. 1412, doi. 10.1111/1756-185X.14607

By:

Ma, Kevin Sheng‐Kai;
Kao, Pei‐En;
Chen, Kun‐Hui;
Liu, Chin‐Hsiu

Publication type:

Article